Corient Private Wealth
MLAB icon

Corient Private Wealth’s Mesa Laboratories MLAB Stock Holding History

Corient Private Wealth’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
+2,423
New +$244K ﹤0.01% 2694

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Corient Private Wealth's MLAB Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 2,423 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2694 among its holdings.

159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Corient Private Wealth held 2,423 shares of Mesa Laboratories worth $241K as of Q2 2026.
  • Mesa Laboratories was a new Corient Private Wealth position in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2694 holding.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.